Cargando…

Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

BACKGROUND: Treatment for non-small cell lung cancer (NSCLC) has greatly improved in recent years. However, noninvasive early screening for carcinogenesis and progression unclear. The aim of this study was to explore the predictive value of peripheral blood immune cells in untreated NSCLC patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yingyi, Zhou, Na, Zhu, Rui, Li, Xiaoyuan, Sun, Zhao, Gao, Yang, Liu, Wei, Meng, Changting, Ge, Yuping, Bai, Chunmei, Li, Taisheng, Liu, Hongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420051/ https://www.ncbi.nlm.nih.gov/pubmed/34488711 http://dx.doi.org/10.1186/s12890-021-01636-x

Ejemplares similares

Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy
por: Li, Ningning, et al.
Publicado: (2023)

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma
por: Tang, Hui, et al.
Publicado: (2023)

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients
por: Geng, Ruixuan, et al.
Publicado: (2023)

Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
por: Liu, Qingyun, et al.
Publicado: (2016)

Circulating exosomal small RNAs are promising non‐invasive diagnostic biomarkers for gastric cancer
por: Ge, Lichen, et al.
Publicado: (2020)

Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression
por: Wang, Ying‐Yi, et al.
Publicado: (2020)

The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer
por: Li, Ningning, et al.
Publicado: (2021)

Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Yuan, Shuai, et al.
Publicado: (2020)

Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
por: Liao, Jipei, et al.
Publicado: (2010)

Circulating exosomes contain protein biomarkers of metastatic non‐small‐cell lung cancer
por: Wang, Ning, et al.
Publicado: (2018)

Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles
por: Liu, Tingting, et al.
Publicado: (2021)

AKAP4 is a circulating biomarker for non-small cell lung cancer
por: Gumireddy, Kiranmai, et al.
Publicado: (2015)

Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer
por: Zhang, Chuantao, et al.
Publicado: (2021)

Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
por: Ge, Yang, et al.
Publicado: (2023)

Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus
por: Li, Wengen, et al.
Publicado: (2020)

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
por: Ai, Bo, et al.
Publicado: (2016)

5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer
por: Zhang, Ji, et al.
Publicado: (2018)

Circulating Complement C1q as a Novel Biomarker is Associated with the Occurrence and Development of COPD
por: Zhang, Ke, et al.
Publicado: (2022)

Progress and application of circulating tumor cells in non-small cell lung cancer
por: Qian, Huizhu, et al.
Publicado: (2021)

The level of circulating endothelial progenitor cells may be associated with the occurrence and recurrence of chronic subdural hematoma
por: Song, Yan, et al.
Publicado: (2013)

5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Early Warning Biomarkers for COVID-19 Progression and Myocardial Injury
por: Chen, Hang-yu, et al.
Publicado: (2022)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression
por: Grimolizzi, Franco, et al.
Publicado: (2017)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

A Generalized Model for Linear-Periodically-Time-Variant Circulators
por: Xu, Changting, et al.
Publicado: (2019)

Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
por: Yu, Xin-Min, et al.
Publicado: (2016)

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients
por: Cao, Lei, et al.
Publicado: (2022)

Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer
por: Duan, Xiaotong, et al.
Publicado: (2021)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Elevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer
por: Zhang, Xiaojun, et al.
Publicado: (2017)

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis
por: Zhu, Hao‐Hua, et al.
Publicado: (2021)

Circulating Tumor Cells as a Biomarker to Assist Molecular Diagnosis for Early Stage Non-Small Cell Lung Cancer
por: He, Yutong, et al.
Publicado: (2020)

Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
por: Wu, Xinyu, et al.
Publicado: (2023)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer
por: Ruan, Mei, et al.
Publicado: (2022)

Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer
por: Liu, Taisheng, et al.
Publicado: (2021)

Overexpression of CD44 is associated with the occurrence and migration of non-small cell lung cancer
por: Li, Guanghu, et al.
Publicado: (2016)

ZNF280A promotes lung adenocarcinoma development by regulating the expression of EIF3C
por: Liu, Hongsheng, et al.
Publicado: (2021)

Circulating biomarkers to monitor cancer progression and treatment
por: Rapisuwon, Suthee, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7nqpm7edvocs1v8t881ltt62gq